Alzheimer; News from the web:
This article from the Guardian brings us five ways to slow down Alzheimer’s onset. For details see the article in our link for today.
Read all about it HERE
Alzheimer; News from the web:
This article from the Guardian brings us five ways to slow down Alzheimer’s onset. For details see the article in our link for today.
Read all about it HERE
Alzheimer; News from the web:
Researchers have now found that slower loss of cognitive skills in people with AD correlates with higher levels of a protein that helps immune cells clear plaque-like cellular debris from the brain [1]. The efficiency of this clean-up process in the brain can be measured via fragments of the protein that shed into the cerebrospinal fluid (CSF). This suggests that the protein, called TREM2, and the immune system as a whole, may be promising targets to help fight Alzheimer’s disease.
Read all about it HERE
Alzheimer; News from the web:
story
Brain scientists are offering a new reason to control blood sugar levels: It might help lower your risk of developing Alzheimer’s disease.
“There’s many reasons to get [blood sugar] under control,” says David Holtzman, chairman of neurology at Washington University in St. Louis. “But this is certainly one.”
Read all about it HERE
Alzheimer; News from the web:
A Birmingham nonprofit organization connects Alzheimer’s, dementia patients with art, see it in our link for today.
Read all about it HERE
Alzheimer; News from the web:
Hispanics who have trouble sleeping may be at a higher risk of Alzheimer’s disease or other dementias, according to a new study.
Read more here: https://www.miamiherald.com/living/health-fitness/article235945087.html#storylink=cpy
Read all about it HERE
Alzheimer; News from the web:
The drug company Biogen is asking the FDA to approve one of its Alzheimer’s treatments, a sign that clinical trials have shown success for the therapy. The drug, aducanumab, is still in the experimental stages, and Biogen had thrown in the towel months ago when studies didn’t seem to show progress. The company now says higher doses may be key. An Alzheimer’s drug gaining FDA approval would be blockbuster. There are currently no effective treatments for the memory-robbing disease, which affects more than 5 million people in the U.S. alone
Read all about it HERE